A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot). [PDF]
Denton CP +19 more
europepmc +1 more source
Association of MMP9 and NOS3 Polymorphisms with Distinct Clinical Forms of Juvenile Scleroderma and Characteristics of Humoral Immunity. [PDF]
Osminina M +13 more
europepmc +1 more source
Generalized Morphea Successfully Treated With Tripterygium Glycosides and Hydroxychloroquine: A Case Report and a Systematic Review. [PDF]
Sun Z, Chen J, Xu X, Zhang J, Yao X.
europepmc +1 more source
Changes on Nailfold Video Capillaroscopy Associate With High-Resolution Esophageal Manometry Findings in Patients With Scleroderma. [PDF]
Li T +5 more
europepmc +1 more source
Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody. [PDF]
Newton NM +11 more
europepmc +1 more source
Autoimmune diseases are associated with increased neurodegenerative and cerebrovascular risk, while systemic corticosteroid exposure shows limited neurodegenerative and modest vascular associations. [PDF]
Tabi YA, Meyer EC.
europepmc +1 more source
Treatment Response of Morphea Patients Referred to a Tertiary Dermatology Hospital: A Three-Year Cohort Study. [PDF]
Kianfar N +7 more
europepmc +1 more source
The relationship between epicardial adipose tissue and mortality in systemic sclerosis patients: 10-year follow-up results. [PDF]
Arslan GY, Söner S.
europepmc +1 more source

